Literature DB >> 235488

T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.

K Bro-Jorgensen, F Güttler, P N Jorgensen, M Volkert.   

Abstract

Plaque-forming cell responses against sheep erythrocytes, Escherichia coli lipopolysaccharide, pneumococcal polysaccharide, and polyvinylpyrrolidone were examined in mice infected with lymphocytic choriomeningitis virus. A 92 to 96 percent reduction of the thymus-dependent anti-sheep erythrocyte responses was observed 2 to 4 weeks after infection. However, the thymus-independent responses against the three other antigens were close to normal at all stages of the infetion. Studies on allograft immunity of infected C3H mice against DBA/2 mastocytoma cells revealed a severe suppression of the T cell-mediated cytotoxic response which was temporally related to the impaired humoral responsiveness against sheep erythrocytes. The capacity of spleen cells from infected mice to restore immune responsiveness of lethally irradiated recipients against sheep erythrocytes was significantly reduced. The adoptive responses, however, were clearly improved when normal thymus cells were added to the inferior spleen cells. Moreover, it appeared that the spleen cells from immunosuppressed donor mice could not confer suppression to normal lymphoid cells. The presented findings are consistent with the assumption that a numeric deficiency of T cells, or cells belonging to some T cell subpopulation, is the primary cause of lymphocytic choriomeningitis virus-induced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235488      PMCID: PMC415113          DOI: 10.1128/iai.11.4.622-629.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Studies on subpopulations of theta-bearing lymphoid cells.

Authors:  L Olsson; M H Claësson
Journal:  Nat New Biol       Date:  1973-07-11

2.  Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells.

Authors:  P Golstein; H Blomgren
Journal:  Cell Immunol       Date:  1973-10       Impact factor: 4.868

Review 3.  Effect of virus infections on the function of the immune system.

Authors:  A L Notkins; S E Mergenhagen; R J Howard
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

4.  Effect of Friend leukemogenic virus on antibody-forming cells to a bacterial somatic antigen.

Authors:  S Hirano; W S Ceglowski; J L Allen; H Friedman
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

5.  Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus.

Authors:  R J Howard; A L Notkins; S E Mergenhagen
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

6.  The immunodepressive action of lymphocytic choriomeningitis virus in mice.

Authors:  C A Mims; S Wainwright
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

7.  Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus.

Authors:  T A Kupers; J M Petrich; A W Holloway; J W St Geme
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

8.  Thymus-dependent lymphocytes: destruction by lymphocytic choriomeningitis virus.

Authors:  M Hanaoka; S Suzuki; J Hotchin
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

9.  Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide.

Authors:  B Andersson; H Blomgren
Journal:  Cell Immunol       Date:  1971-10       Impact factor: 4.868

10.  Frequency of antigen-sensitive cells to thymus-independent antigens.

Authors:  G Möller; G Michael
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

View more
  9 in total

1.  Directions for future research on the pathogenesis of arenaviral infections.

Authors:  N Nathanson
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Generation in vitro of alloreactive lymphocytes is suppressed by the addition of spleen cells from mice infected with lymphocytic choriomeningitis virus.

Authors:  M Varho-Göbel; G Wolff; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

4.  Persistent LCM virus infection in the mouse. Immunity and tolerance.

Authors:  M Volkert; K Bro-Jorgensen; O Marker
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

5.  The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.

Authors:  A R Thomsen; O Marker
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

6.  Lymphocytic choriomeningitis virus-induced immunosuppression: evidence for viral interference with T-cell maturation.

Authors:  A R Thomsen; K Bro-Jørgensen; B L Jensen
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius.

Authors:  M P Arala-Chaves; T B Higerd; M T Porto; J Munoz; J M Goust; H H Fudenberg; C B Loadholt
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Cell-mediated immunity and lymphocyte populations in experimental Argentine hemorrhagic fever (Junín Virus).

Authors:  G Carballal; J R Oubiña; S N Rondinone; B Elsner; M J Frigerio
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

9.  Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus.

Authors:  S L Silberman; R P Jacobs; G A Cole
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.